GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Gross Margin %

PharmaRoth Labs (PharmaRoth Labs) Gross Margin % : 40.00% (As of Mar. 2011)


View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. PharmaRoth Labs's Gross Profit for the three months ended in Mar. 2011 was $0.08 Mil. PharmaRoth Labs's Revenue for the three months ended in Mar. 2011 was $0.20 Mil. Therefore, PharmaRoth Labs's Gross Margin % for the quarter that ended in Mar. 2011 was 40.00%.


The historical rank and industry rank for PharmaRoth Labs's Gross Margin % or its related term are showing as below:


ROTH's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 59.74
* Ranked among companies with meaningful Gross Margin % only.

PharmaRoth Labs had a gross margin of 40.00% for the quarter that ended in Mar. 2011 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for PharmaRoth Labs was 0.00% per year.


PharmaRoth Labs Gross Margin % Historical Data

The historical data trend for PharmaRoth Labs's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Gross Margin % Chart

PharmaRoth Labs Annual Data
Trend Jun08 Jun09 Jun10
Gross Margin %
- - -

PharmaRoth Labs Quarterly Data
Mar07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 40.00

Competitive Comparison of PharmaRoth Labs's Gross Margin %

For the Biotechnology subindustry, PharmaRoth Labs's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaRoth Labs's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaRoth Labs's Gross Margin % distribution charts can be found below:

* The bar in red indicates where PharmaRoth Labs's Gross Margin % falls into.



PharmaRoth Labs Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

PharmaRoth Labs's Gross Margin for the fiscal year that ended in Jun. 2010 is calculated as

Gross Margin % (A: Jun. 2010 )=Gross Profit (A: Jun. 2010 ) / Revenue (A: Jun. 2010 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

PharmaRoth Labs's Gross Margin for the quarter that ended in Mar. 2011 is calculated as


Gross Margin % (Q: Mar. 2011 )=Gross Profit (Q: Mar. 2011 ) / Revenue (Q: Mar. 2011 )
=0.1 / 0.2
=(Revenue - Cost of Goods Sold) / Revenue
=(0.2 - 0.12) / 0.2
=40.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


PharmaRoth Labs  (GREY:ROTH) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

PharmaRoth Labs had a gross margin of 40.00% for the quarter that ended in Mar. 2011 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


PharmaRoth Labs Gross Margin % Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaRoth Labs (PharmaRoth Labs) Business Description

Traded in Other Exchanges
N/A
Address
8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117
PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines